SEALSQ (LAES) had the highest return between December 27, 2023 and January 15, 2024 by a small-cap US stock, returning 101.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
SEALSQ (LAES) | 12/27/2023 - 1/15/2024 | 101.79% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/15/2024 | 59.64% |
Here (HERE) | 12/27/2023 - 1/15/2024 | 59.64% |
Richtech Robotics Inc Class B Common Stock (RR) | 12/27/2023 - 1/15/2024 | 44.67% |
ATAI Life Sciences (ATAI) | 12/27/2023 - 1/15/2024 | 44.12% |
Real Brokerage (REAX) | 12/27/2023 - 1/15/2024 | 42.04% |
Qilian International (BGM) | 12/27/2023 - 1/15/2024 | 41.51% |
Ardelyx (ARDX) | 12/27/2023 - 1/15/2024 | 38.28% |
POET Technologies (POET) | 12/27/2023 - 1/15/2024 | 37.78% |
Sana Biotechnology (SANA) | 12/27/2023 - 1/15/2024 | 36.9% |
Corvus Pharmaceuticals (CRVS) | 12/27/2023 - 1/15/2024 | 34.48% |
Yirendai (YRD) | 12/27/2023 - 1/15/2024 | 34.21% |
Verastem (VSTM) | 12/27/2023 - 1/15/2024 | 33.21% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/15/2024 | 29.53% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/27/2023 - 1/15/2024 | 29.44% |
ADC Therapeutics (ADCT) | 12/27/2023 - 1/15/2024 | 29.09% |
I-Mab (IMAB) | 12/27/2023 - 1/15/2024 | 28.93% |
Aquestive Therapeutics (AQST) | 12/27/2023 - 1/15/2024 | 28.92% |
Bright Minds Biosciences (DRUG) | 12/27/2023 - 1/15/2024 | 28.73% |
Akebia Ther (AKBA) | 12/27/2023 - 1/15/2024 | 28.1% |
Mereo BioPharma Group PLC ADR (MREO) | 12/27/2023 - 1/15/2024 | 27.71% |
Iovance Biotherapeutics (IOVA) | 12/27/2023 - 1/15/2024 | 27.62% |
Capital Clean Energy Carriers (CCEC) | 12/27/2023 - 1/15/2024 | 27.14% |
Jiayin (JFIN) | 12/27/2023 - 1/15/2024 | 25.67% |
American Public Education (APEI) | 12/27/2023 - 1/15/2024 | 25.62% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
